In vivo evaluation of poly-l-asparagine nanocapsules as carriers for anti-cancer drug delivery - Université d'Angers Accéder directement au contenu
Article Dans Une Revue International Journal of Pharmaceutics Année : 2013

In vivo evaluation of poly-l-asparagine nanocapsules as carriers for anti-cancer drug delivery

Résumé

Here, we report the in vivo proof of-concept of a novel nanocarrier, poly-l-asparagine (PASN) nanocapsules, as an anticancer targeted drug delivery system. The nanocapsules were loaded with the fluorescent marker DiD (1,1'-dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine perchlorate) and also with the model drug docetaxel to evaluate the biodistribution and efficacy profiles in healthy and glioma-bearing mice, respectively. Regardless of their cargo, the nanocapsules presented a size close to 180 nm, a surface charge around -40 mV and an encapsulation efficiency of 75-90%. The biodistribution study in healthy mice showed that PASN nanocapsules led to a two- and three-fold increment in the mean residence time (MRT) and area under the curve (AUC) values, respectively, compared to those of a non-polymeric nanoemulsion. Finally, the efficacy/toxicity study indicated that the encapsulated drug was as efficacious as the commercial formulation (Taxotere(®)), with the additional advantage of being considerably less toxic. Overall, these results suggest the potential of PASN nanocapsules as drug nanocarriers in anticancer therapy.

Fichier principal
Vignette du fichier
rivera-rodriguez_2013_in_vivo_evaluation_of_poly-l-asparagine_nanocapsules_as_carriers_for_anti-cancer_drug_delivery.pdf (883.95 Ko) Télécharger le fichier
Origine : Accord explicite pour ce dépôt

Dates et versions

hal-03178899 , version 1 (24-03-2021)

Identifiants

Citer

Gustavo Rivera-Rodriguez, Giovanna Lollo, Tristan Montier, Jean-Pierre Benoit, Catherine Passirani-Malleret, et al.. In vivo evaluation of poly-l-asparagine nanocapsules as carriers for anti-cancer drug delivery. International Journal of Pharmaceutics, 2013, 458 (1), pp.83-9. ⟨10.1016/j.ijpharm.2013.09.038⟩. ⟨hal-03178899⟩
22 Consultations
114 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More